Trial intelligence / Profile preview

Comparison of Different Doses of LetibotulinumtoxinA vs Normal Saline for Intradermal Face-Lifting (Split-Face RCT)

TCTR20220720011Phase 4Completed

Sponsor
Siriraj Hospital
Start
Mar 2017
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of letibotulinumtoxinA in cutaneous aging, sponsored by Siriraj Hospital. Started Mar 2017; status: completed.

02

Drugs

letibotulinumtoxinA
03

Conditions

cutaneous aging

Beyond the preview

Go deeper on TCTR20220720011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220720011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call